LifeMD, Inc.

LFMD Healthcare Health Information Services

LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

2.34 0.12 −4.88%
Market cap
$118.6M
P/E
0.0×
Fwd P/E
−17.9×
Dividend yield
—
F-score
6/9
Altman Z
−0.02
Beneish M
−3.67
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 13.12 72.20 0.00
P/S ratio
1.88 0.79 0.88 1.03
P/FCF ratio
101.82 0.00 0.00 0.00
P/Operating CF
(2,130.84) (46.91) 384.35 (28.50)
P/B ratio
93.07 6.65 11.36 24.77
Price to Tangible BV
173.20 6.72 11.54 25.41
EV/Sales
1.83 0.68 0.79 0.98
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
24.15 16.01 26.85 (18.94)
EV/FCF
99.12 (106.73) (38.76) (10.27)
Quick Ratio
0.58 1.11 0.89 0.78
Current Ratio
0.73 1.25 1.04 0.90
Net Debt/EBITDA
(7.77) 11.03 4.97 4.94
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
2.41 2.65 2.69 2.87
Operating CF/Net income
0.03 (0.17) (0.05) 0.88
Capex/Depreciation
(1.06) (0.55) (1.03) (0.80)
Interest Coverage
(7.50) (3.42) 158.04 —
Research and Development Expense of Revenue
4.73% 2.41% 3.58% 3.79%
Selling, General and Administrative Expense of Revenue
76.55% 72.83% 89.81% 88.16%
Intangible Assets out of Total Assets
0.02 0.00 0.00 0.00
Share Based Compensation of Revenue
5.31% 7.81% 2.89% 1.67%
Graham Net Nets
(0.07) 0.03 (0.02) (0.05)
Graham Number
0.00 1.73 0.60 0.00
Earnings Yield
(2.50%) 7.62% 1.39% (1.21%)
Free Cash Flow Yield
0.98% (0.81%) (2.29%) (9.26%)
Revenue per Share
1.30 0.75 1.06 0.99
Operating CF per Share
0.00 (0.07) 0.01 (0.14)
Capex per Share
(0.12) 0.01 (0.04) (0.03)
Free Cash Flow per Share
(0.12) (0.06) (0.03) (0.18)
Cash per Share
0.52 0.82 0.73 0.53
Shareholders Equity per Share
0.07 0.51 0.32 0.17
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.07 0.51 0.32 0.17
Free Cash Flow
(5.47) (2.64) (1.61) (8.56)
Working Capital
(15.58) 10.26 2.11 (4.52)
Capital Expenditures
(5.32) 0.64 (2.06) (1.63)
Net Current Asset Value
(21.53) 4.58 (3.39) (9.84)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.09 (0.02) 0.04 0.03
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
7.65 9.88 10.02 9.29
Average Payables
17.71 12.53 18.67 21.22
Average Inventory
3.04 2.79 3.07 3.10
Average Assets
69.27 73.25 71.87 66.73
Average Common Equity
(1.29) 7.80 7.32 4.17

Fold the line items

Columns are period end dates